Article
The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches
14 Apr 2022
Abstract excerpt
BACKGROUND: Risk stratification or progression in prostate cancer is performed with the support of clinical-pathological data such as the sum of the Gleason score and serum levels PSA. For several decades, methods aimed at the early detection of prostate cancer have included the determination of PSA serum levels. The aim of this systematic review is to provide an overview about recent advances in the discovery of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
